BioSpace News Archive

Nordic Nanovector ASA announces that it will present a poster describing a preclinical analysis of genetic factors that correlate with the responsiveness of non-Hodgkin’s lymphoma (NHL) cell lines to Betalutin® (177Lu-lilotomab satetraxetan) at the 23rd annual meeting of the European Hematology Association (EHA) (Stockholm, Sweden, 14-17 June).

Innovus Pharmaceuticals, Inc. announced that Dr. Bassam Damaj, its President and Chief Executive Officer, will speak at the 8th Annual LD Micro Invitational Conference.

TapImmune Inc. announced that its President and CEO, Peter L. Hoang, will present at the Jefferies 2018 Global Healthcare Conference.

Teleflex Incorporated will showcase the LMA® Gastro™ Airway and other key products in its Anesthesia portfolio, together with its innovative Vascular Access platform, at the Euroanesthesia Congress.

Canopy Rivers Corporation (“Canopy Rivers”, or the “Company”) is pleased to announce its newly appointed, majority independent Board of Directors, as well as a number of strategic appointments to its management team.

Good Samaritan Hospital has received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Silver Plus Quality Achievement Award.

Encision Inc. applauded the FDA’s issuance of a safety communication.

Recovery Centers of America (RCA) announced that its Westminster, Mass., facility has expanded the number of Clinical Support Services (CSS) beds from 32 to 48.

Ra Pharmaceuticals, Inc. announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference.

Mr. Falholt previously served as the head of Novozymes R&D. Mr. Deshmukh most recently served as the Executive Director of R&D IT at Merck Sharp & Dohme.